205 related articles for article (PubMed ID: 32443286)
21. Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer.
Yang Y; Liu R; Ren F; Guo R; Zhang P
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30446526
[No Abstract] [Full Text] [Related]
22. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
23. Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis.
Liu JF; Ba L; Lv H; Lv D; Du JT; Jing XM; Yang NJ; Wang SX; Li C; Li XX
Sci Rep; 2016 Dec; 6():38551. PubMed ID: 27941815
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
25. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
26. Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis.
Sun J; Chen X; Gao P; Song Y; Huang X; Yang Y; Zhao J; Ma B; Gao X; Wang Z
Dis Markers; 2016; 2016():7862469. PubMed ID: 26924872
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.
Xue TC; Zhang L; Xie XY; Ge NL; Li LX; Zhang BH; Ye SL; Ren ZG
PLoS One; 2014; 9(5):e96072. PubMed ID: 24788770
[TBL] [Abstract][Full Text] [Related]
28. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis.
Li Y; Xu T; Wang X; Jia X; Ren M; Wang X
Cancer Cell Int; 2023 Feb; 23(1):39. PubMed ID: 36855112
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis.
Liu X; Qu JK; Zhang J; Yan Y; Zhao XX; Wang JZ; Qu HY; Liu L; Wang JS; Duan XY
Medicine (Baltimore); 2017 Nov; 96(45):e8101. PubMed ID: 29137007
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and clinicopathologic significance of neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma: evidence from a meta-analysis.
Huang Y; Sun Y; Peng P; Zhu S; Sun W; Zhang P
Onco Targets Ther; 2017; 10():1165-1172. PubMed ID: 28260931
[TBL] [Abstract][Full Text] [Related]
31. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis.
Chen N; Liu S; Huang L; Li W; Yang W; Cong T; Ding L; Qiu M
Oncotarget; 2017 Aug; 8(34):57460-57469. PubMed ID: 28915685
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of neutrophil-to-lymphocyte ratio in rectal cancer: a meta-analysis.
Dong YW; Shi YQ; He LW; Su PZ
Onco Targets Ther; 2016; 9():3127-34. PubMed ID: 27307753
[TBL] [Abstract][Full Text] [Related]
36. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
37. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
38. The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.
Min GT; Li YM; Yao N; Wang J; Wang HP; Chen W
Clin Transplant; 2018 Jan; 32(1):. PubMed ID: 29112283
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis.
Liu G; Ke LC; Sun SR
Medicine (Baltimore); 2018 Sep; 97(36):e12176. PubMed ID: 30200120
[TBL] [Abstract][Full Text] [Related]
40. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
